Gene: CADM1
Official Full Name: cell adhesion molecule 1provided by VGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01282 | CADM1 Knockout cell line(MDCK) | Dog | CADM1 | 1:3~1:4 | Negative | Online Inquiry |
KO01747 | CADM1 Knockout cell line (HeLa) | Human | CADM1 | 1:3~1:6 | Negative | Online Inquiry |
KO01748 | CADM1 Knockout cell line (HEK293) | Human | CADM1 | 1:3~1:6 | Negative | Online Inquiry |
KO01749 | CADM1 Knockout cell line (A549) | Human | CADM1 | 1:3~1:4 | Negative | Online Inquiry |
CADM1 Gene Knockout Cell Lines are specifically engineered cellular systems designed to investigate the functional role of the CADM1 gene, which encodes for a cell adhesion molecule implicated in various cellular processes, including proliferation, differentiation, and tumor suppression. Utilizing CRISPR/Cas9 gene-editing technology, these cell lines have undergone precise modifications to eliminate the CADM1 gene, enabling researchers to study the downstream effects and biochemical pathways activated in its absence.
The primary function of CADM1 knockout cell lines is to facilitate the exploration of cellular mechanisms associated with CADM1 loss, particularly in cancer research and developmental biology. By providing a controlled environment, these cell lines allow for the observation of altered cell behavior, gene expression profiles, and signaling cascades, thus advancing our understanding of tissue development, immune responses, and the pathogenesis of various diseases.
The scientific importance of CADM1 gene knockout cell lines is underscored by their potential applications in both research and clinical settings. They serve as crucial models for characterizing tumor microenvironments, evaluating therapeutic interventions, and testing the efficacy of novel compounds aimed at targeting CADM1-related pathways. Additionally, they can assist in developing personalized medicine strategies by elucidating unique biological responses in CADM1-deficient cells.
Compared to traditional knockout models, which may involve extensive breeding protocols, our CADM1 gene knockout cell lines offer a streamlined, ready-to-use alternative that enhances experimental reproducibility and accelerates research timelines. The precision of gene editing also minimizes the risk of off-target effects, providing reliable data outcomes.
For researchers and clinicians, these cell lines represent a powerful tool in unraveling complex biological interactions and disease mechanisms. Their easy integration into existing experimental workflows, combined with in-depth support from our experienced team, ensures that users can maximize their research potential effectively.
Our company prides itself on advancing scientific discovery through quality biological products and outstanding support, reflecting our commitment to empowering researchers with the tools necessary to push the boundaries of knowledge in cellular and molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.